2020
DOI: 10.21203/rs.3.rs-16418/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

High serum IgA and proportion of activated Th17 and Treg predict efficacy of abatacept in patients with early, seropositive rheumatoid arthritis

Abstract: Background To identify the predictive biomarkers for achieving remission with abatacept in patients

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 43 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?